Reata Pharmaceuticals Inc... (RETA)
NASDAQ: RETA
· Real-Time Price · USD
172.36
0.04 (0.02%)
At close: Sep 25, 2023, 10:00 PM
Reata Pharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | 193M | -116.12M | -85.5M | -79M | -73.56M | -73.84M | -85.39M | -71.85M | -72.7M | -67.45M |
Depreciation & Amortization | 293K | 288K | 277K | 272K | 273K | 308K | 323K | 319K | 287K | 274K |
Stock-Based Compensation | 20.36M | 38.06M | 14.98M | 14.45M | 13.86M | 15.44M | 15.23M | 13.66M | 13.24M | 14.68M |
Other Working Capital | 3.88M | -2.67M | -436K | 8.39M | 1.6M | -5.44M | -78.54M | 8.59M | 20.45M | -8.78M |
Other Non-Cash Items | 6.71M | 9.06M | 8.84M | 9.82M | 9.93M | 9.87M | 13.62M | 13.79M | 13.2M | 12.64M |
Deferred Income Tax | -291.96M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 1.67M | -12.74M | 10.98M | 7.93M | 366K | -9.97M | -66.71M | 1.92M | 20.37M | -5.15M |
Operating Cash Flow | -69.93M | -81.45M | -50.43M | -46.53M | -49.12M | -58.19M | -122.93M | -42.16M | -25.6M | -45.01M |
Capital Expenditures | -274K | -141K | -367K | -341K | -2.27M | -288K | -193K | -674K | -269K | -193K |
Cash Acquisitions | n/a | n/a | 75M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -240.09M | -63.86M | -184.13M | -143.8M | -333.97M | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 197.42M | 175M | 245M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | -75M | 75M | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -42.95M | 111M | 60.51M | -69.14M | -336.24M | -288K | -193K | -674K | -269K | -193K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | 22.65M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | 13.08M | 314K | 436K | 541K | 194K | 171K | 337K | n/a | 4.68M |
Financial Cash Flow | 76.78M | 13.08M | 314K | 436K | 541K | 194K | 171K | 337K | 3.95M | 4.68M |
Net Cash Flow | -36.1M | 42.63M | 10.39M | -115.24M | -384.82M | -58.28M | -122.95M | -42.49M | -21.92M | -40.53M |
Free Cash Flow | -70.2M | -81.59M | -50.79M | -46.88M | -51.4M | -58.47M | -123.13M | -42.83M | -25.87M | -45.2M |